65,437 trials
Bacterial Conjunctivitis
Primary: Exploratory Outcomes From Digital Photography — 17; 7 Participants
Pulmonary Hypertension
Primary: Number of Subjects With Adverse Events (AEs) and Serious Adverse Events (SAEs) — 11; 8; 8; 2 participants
Osteoarthritis
Primary: Average Daily Pain Scores - BS11 Pain Scores. — 3; 3 Box Scale 11 boxes
Patient Indicated for an ICD
Primary: Home Monitoring Effectiveness — 2.1; 3.8 In-office ICD follow-up per patient year — p=<0.001
Non-Small Cell Lung Cancer
Primary: Overall Survival — 11.7; 12.2; 11.4; 11.5 months — p=0.4921
Kidney Failure, Chronic · Diabetic Nephropathies · Glomerulonephritis, IGA
Primary: The Number of Subjects With a 10% Decrease in PRA Level at Month 8. — 9 Participant
Thyroid Cancer
Primary: Number of Persons That Are Vitamin D Deficient in the Thyroid Nodule, Thyroid Cancer in Remission, and the Active Thyroid Cancer Groups. — 23; 20; 11 participants…
HIV Infections · Acquired Immunodeficiency Syndrome
Primary: Change From Baseline in Plasma Human Immunodeficiency Virus (HIV) Ribonucleic Acid (RNA) on Day 10 (Cohort I) — -1.93; -1.98; -1.66; -2.16 copies/mL
Kidney Failure, Chronic · Diabetic Nephropathies · Glomerulonephritis, IGA
Primary: The Number of Subjects Who Experience a Decrease in Their Panel of Reactive Antibodies (PRA) at 6 Months Post Rituximab Infusion. — 6 Participants
Atrial Fibrillation · Vascular Risk
Primary: First Occurence of Any Component of the Composite of Stroke, Non-Central Nervous System (Non-CNS) Systemic Embolism, Myocardial Infarction or Vascular Death as Per…
Leukemia, Myelocytic, Acute
Primary: Minimal Residual Disease (MRD). — 31; 43; 68; 63 participants — p=.1559
Nasopharyngeal Carcinoma
Primary: 3 Month Loco-regional Control After Cetuximab With Concurrent Chemoradiotherapy — 100 participants with loco-regional control
Asthma
Primary: Change in Mean of Total Score of Asthma Control Questionnaire (ACQ) — -0.76; -0.37 points on a scale — p=<0.0001
Polyps
Primary: Numbers of Participants With Successful Deployment of Tissue Apposition System (TAS) — 6 participants
Tracheal Intubation
Primary: Intubation Time — 47.0; 29.5 seconds — p=<0.01